Stem cell therapies for periodontal tissue regeneration: a network meta-analysis of preclinical studies
2020 · Stem Cell Research & Therapy · 93 citations
https://doi.org/10.1186/s13287-020-01938-7
M
Meng Ding
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
2.7K
Citations
28
h-index
61
i10-index
Meng Ding is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & MicroRNA in disease regulation & RNA modifications and cancer. The author has an h-index of 28, co-authored 84 publications.
ORCID: 0000-0003-4042-2526Papers by this author
worksIncreased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome
2018 · EBioMedicine · 80 citations
https://doi.org/10.1016/j.ebiom.2018.11.018
Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer
2024 · Molecular Cancer · 36 citations
https://doi.org/10.1186/s12943-024-01945-9
Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p
2022 · Cell Death Discovery · 31 citations
https://doi.org/10.1038/s41420-022-01219-7
Decreased miR‐200a‐3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL
2018 · Journal of Cellular Biochemistry · 24 citations
https://doi.org/10.1002/jcb.27326
Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers
2022 · Cancer Cell International · 24 citations
https://doi.org/10.1186/s12935-022-02467-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat